title: Undertreatment of dyslipidemia: from the Arabian Gulf to the USA. Time to solve this problem!
abstract: Undertreatment of dyslipideamia is a universal problem and reduces the efficasy of hypolipidaemic drugs to reduce cardiovascular event rates. The means to face this problem are available and should be utilized to optimize dyslipidaemia control and clinical outcomes.
authors.affiliation: Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital , Thessaloniki , Greece.
authors.forename: Vasilios G
authors.initials: VG
authors.lastname: Athyros
authors.forename: Niki
authors.initials: N
authors.lastname: Katsiki
authors.forename: Manfredi
authors.initials: M
authors.lastname: Rizzo
mesh_terms: D001054:Apolipoproteins A / Q000097:blood; D001055:Apolipoproteins B / Q000097:blood; D002784:Cholesterol / Q000097:blood; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008877:Middle East / Q000453:epidemiology; D014280:Triglycerides / Q000097:blood
chemical_list: D001054:Apolipoproteins A; D001055:Apolipoproteins B; D000960:Hypolipidemic Agents; D014280:Triglycerides; D002784:Cholesterol
keywords: Arab Gulf; Clinical benefit; Measures to improve adherence; Measures to improve lipid goal attainment; Undertreatment of dyslipidemia